Tina Susan Nova

CIK: 0001302605

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

XGN

EXAGEN INC.

Director

AUPH

Aurinia Pharmaceuticals Inc.

Director

AZTA

Azenta, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

XGN
EXAGEN INC.
Jun 9, 2026
Award(A)
Stock Option(right to buy)
Direct
56.2K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Jun 4, 2026
Award(A)
Director Stock Option (right to buy)
Direct
23.9K shares-
AZTA
Azenta, Inc.
Feb 6, 2026
Award(A)
Direct
5.7K shares at avg. $27.85$158K
XGN
EXAGEN INC.
Jun 10, 2025
Award(A)
Stock Option(right to buy)
Direct
13.5K shares-
AUPH
Aurinia Pharmaceuticals Inc.
May 16, 2025
Award(A)
Director Stock Option (right to buy)
Direct
63.7K shares-
AZTA
Azenta, Inc.
Feb 7, 2025
Award(A)
Direct
4K shares at avg. $52.32$211K

		Type	Shares	Price		Ownership
Jun 9, 2026	XGN EXAGEN INC.	Award(A) Stock Option(right to buy)	56,200	-	-	Direct
Jun 4, 2026	AUPH Aurinia Pharmaceuticals Inc.	Award(A) Director Stock Option (right to buy)	23,931	-	-	Direct
Feb 6, 2026	AZTA Azenta, Inc.	Award(A)	5,663	$27.85	$157,715	Direct
Jun 10, 2025	XGN EXAGEN INC.	Award(A) Stock Option(right to buy)	13,500	-	-	Direct
May 16, 2025	AUPH Aurinia Pharmaceuticals Inc.	Award(A) Director Stock Option (right to buy)	63,724	-	-	Direct
Feb 7, 2025	AZTA Azenta, Inc.	Award(A)	4,040	$52.32	$211,373	Direct

1-6 of 6 transactions

About Nova Tina Susan

Nova Tina Susan (SEC CIK 0001302605) files insider reports with the SEC as Director of EXAGEN INC. (XGN), Director of Aurinia Pharmaceuticals Inc. (AUPH) and Director of Azenta, Inc. (AZTA).

Signal8 holds 7 ownership filings by Nova Tina Susan (1 Form 3, 6 Form 4), filed between Feb 11, 2025 and Nov 2, 2026. Those filings report 6 transactions, from Feb 7, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nova Tina Susan's filings is in VISTA, CA.

Recent filings by Nova Tina Susan

Jun 9, 2026: Grant or award of XGN derivative securities (Form 4, code A).
Jun 4, 2026: Grant or award of AUPH derivative securities (Form 4, code A).
Feb 6, 2026: Grant or award of AZTA shares (Form 4, code A).
Jun 10, 2025: Grant or award of XGN derivative securities (Form 4, code A).
May 16, 2025: Grant or award of AUPH derivative securities (Form 4, code A).

Other insiders filing for EXAGEN INC. (XGN)

Chernett Jorey, 10% Owner
ABALLI JOHN, President and CEO
Black Jeffrey G., Chief Financial Officer
Robertson Bruce C, Director
Kim Paul, Director
KAHN SCOTT D, Director

How to read Form 4 transaction codes